Purchase Order 75F40123P00081
Award Date
4/20/23
Potential Completion Date
4/30/28
Potential Value
$90K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Winchester, MA 01890, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $70,930.76, is for preventive maintenance and repair services for Illumina's MiSeq genetic sequencing instruments. The contract has an ultimate completion date of August 31, 2025 and does not utilize any set-aside designations. Illumina is a specialized technology provider...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
This firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for preventative maintenance on a MiSeq benchtop sequencer, with a potential value of $26,157.45 and a completion date of September 29, 2018. Illumina has a history of providing sequencing systems and related products and services to support genomic research and diagnostics at...
This is a $58,464.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventive maintenance services on two (2) Illumina MiSeq instruments. The award has an ultimate completion date of July 19, 2027 and does not utilize any set-aside designations. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has been awarded numerous past federal prime contracts and subcontracts across agencies such as the NIH, CDC, USDA,...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a ceiling value of $217,662.22 and is for the provision of a MiSeq benchtop sequencer, associated reagent kits, and preventative maintenance services. The contract does not utilize any set-aside designations. Illumina has a history of providing sequencing systems, reagents, and support services to...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance and reagents for the company's MiSeq benchtop sequencer. The total ceiling value of the contract is $292,446.20, with a performance period ending on December 5, 2016. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to support genomic research and diagnostics for...
The Department of Health and Human Services Food and Drug Administration awarded a $474,577.44 firm fixed price purchase order for preventive maintenance and repair services for Illumina, Inc.'s MiSeq DNA sequencing systems. The contract was awarded on December 4, 2017 with a completion date of December 5, 2019. Illumina is a manufacturer of a range of genetic and genomic analysis instruments and reagents, and has provided similar products and services to support research and diagnostics at...